4.7 Article

Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair deficient colorectal cancer tissue

Journal

JCI INSIGHT
Volume 6, Issue 14, Pages -

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/jci.insight.146356

Keywords

-

Funding

  1. Japan Agency for Medical Research and Development (AMED) [JP19cm0106352]
  2. Japan Society for the Promotion of Science (JSPS) KAKENHI [JP19H03490, JP20K21528]
  3. Takeda Science Foundation
  4. AMED [JP20cm0106309, 20gm1110011h0002]
  5. JSPS KAKENHI [JP17H01540, JP15H05909]
  6. JST CREST [JPMJCR15G3]

Ask authors/readers for more resources

The study identified a rare neoantigen in mismatch repair-deficient colorectal cancer tissue, which was associated with abundant tumor-infiltrating lymphocytes and an inflamed gene expression status. CD8(+) TILs predominantly recognized the detected neoantigen and exhibited functional and specific responses.
Although CD8(+) T cells recognize neoantigens that arise from somatic mutations in cancer, only a small fraction of nonsynonymous mutations give rise to clinically relevant neoantigens. In this study, HLA class I ligandomes of a panel of human colorectal cancer (CRC) and matched normal tissues were analyzed using mass spectrometry-based proteogenomic analysis. Neoantigen presentation was rare; however, the analysis detected a single neoantigen in a mismatch repair-deficient CRC (dMMR-CRC) tissue sample carrying 3967 nonsynonymous mutations, where abundant tumor-infiltrating lymphocytes (TILs) and inflamed gene expression status were observed in the tumor microenvironment (TME). Using the HLA class I ligandome data and gene expression profiles, a set of nonmutated tumor-associated antigen (TAA) candidates was concomitantly identified. Interestingly, CD8(+) TILs predominantly recognized the detected neoantigen over the array of TAA candidates. Neoantigen- reactive CD8(+) TILs showed PD-1 positivity and exhibited functional and specific responses. Moreover, T cell receptor (TCR) profiling identified the sequence of the neoantigen-reactive TCR clonotype and showed its expansion in the TME. Transduction of the sequenced TCR conferred neoantigen specificity and cytotoxicity to peripheral blood lymphocytes. The proteogenomic approach revealed the antigenic and reactive T cell landscape in dMMR-CRC, demonstrating the presence of an immunogenic neoantigen and its potential therapeutic applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available